Cart
sales@molnova.com
JCP251
CAS No. 62252-26-0
JCP251( JCP-251 | JCP 251 )
Catalog No. M15354 CAS No. 62252-26-0
JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 163 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 223 | In Stock |
|
| 25MG | 373 | In Stock |
|
| 50MG | 520 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJCP251
-
NoteResearch use only, not for human use.
-
Brief DescriptionJCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
-
DescriptionJCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsJCP-251 | JCP 251
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62252-26-0
-
Formula Weight225.628
-
Molecular FormulaC10H8ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1OC(OC)=C(Cl)C2=C1C=C(N)C=C2
-
Chemical Name7-amino-4-chloro-3-methoxy-1H-isochromen-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lentz CS, et al. Nat Chem Biol. 2018 May 16. doi: 10.1038/s41589-018-0060-1.
molnova catalog
related products
-
Rifamycin sodium sal...
Rifamycin is an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. It is effective against Gram-positive bacteria.
-
Ribocil
Ribocil is a synthetic mimic of riboflavin 5’-monophosphate (FMN) that competes with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB.
-
Meptyldinocap
A novel powdery mildew (Erysiphe necator) fungicide that shows protectant and post-infective activities.
